Home  »  Finance   »  Selling Your Cocrystal Pharma Inc. (NASDAQ: COCP) ...

Selling Your Cocrystal Pharma Inc. (NASDAQ: COCP) Stock? Here’s What You Need To Know

Cocrystal Pharma Inc. (NASDAQ:COCP) shares, rose in value on Friday, May 13, with the stock price up by 4.25% to the previous day’s close as strong demand from buyers drove the stock to $0.40.

Actively observing the price movement in the recent trading, the stock is buoying the session at $0.38, falling within a range of $0.3713 and $0.4189. The value of beta (5-year monthly) is 0.62. Referring to stock’s 52-week performance, its high was $1.49, and the low was $0.37. On the whole, COCP has fluctuated by -25.52% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.


With the market capitalization of Cocrystal Pharma Inc. currently standing at about $41.16 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 15, 2022 – Mar 21, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.04, which is expected to increase to -$0.04 for fiscal year -$0.16 and then to about -$0.16 by fiscal year 2022.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that COCP’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of COCP currently trading nearly -15.47% and -21.60% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 29.25, while the 7-day volatility ratio is showing 11.80% which for the 30-day chart, stands at 7.20%. Furthermore, Cocrystal Pharma Inc. (COCP)’s beta value is 0.80, and its average true range (ATR) is 0.03.

Data on historical trading for Cocrystal Pharma Inc. (NASDAQ:COCP) indicates that the trading volumes over the past 3 months, they’ve averaged 278.33K. According to company’s latest data on outstanding shares, there are 97.57 million shares outstanding.

Nearly 15.89% of Cocrystal Pharma Inc.’s shares belong to company insiders and institutional investors own 22.10% of the company’s shares. The stock has fallen by -40.97% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the COCP stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts



Download Free eBook For


100% free. stop anytime no spam